Interleukin-2 receptor and ovarian cancer.

Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 women, of whom 30 were diagnosed as having malignant ovarian tumours, five had non ovarian tumours, one had a negative second look laparotomy, 11 had benign ovarian tumours, three had uterine fibroids...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, O. J., Taggart, C., Wilson, R., Walker, J. J., McKillop, J. H., Kennedy, J. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968563/
https://www.ncbi.nlm.nih.gov/pubmed/8347492
_version_ 1782134767737634816
author Owens, O. J.
Taggart, C.
Wilson, R.
Walker, J. J.
McKillop, J. H.
Kennedy, J. H.
author_facet Owens, O. J.
Taggart, C.
Wilson, R.
Walker, J. J.
McKillop, J. H.
Kennedy, J. H.
author_sort Owens, O. J.
collection PubMed
description Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 women, of whom 30 were diagnosed as having malignant ovarian tumours, five had non ovarian tumours, one had a negative second look laparotomy, 11 had benign ovarian tumours, three had uterine fibroids and 28 were age-matched controls. The results indicated that the serum IL-2R of these patients was significantly elevated in ovarian cancer patients compared to both controls (P < 0.0001) and benign ovarian tumours (P < 0.0002). There were no significant differences in IL-2R levels between stage of disease and degree of differentiation within the ovarian tumour group.
format Text
id pubmed-1968563
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19685632009-09-10 Interleukin-2 receptor and ovarian cancer. Owens, O. J. Taggart, C. Wilson, R. Walker, J. J. McKillop, J. H. Kennedy, J. H. Br J Cancer Research Article Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 women, of whom 30 were diagnosed as having malignant ovarian tumours, five had non ovarian tumours, one had a negative second look laparotomy, 11 had benign ovarian tumours, three had uterine fibroids and 28 were age-matched controls. The results indicated that the serum IL-2R of these patients was significantly elevated in ovarian cancer patients compared to both controls (P < 0.0001) and benign ovarian tumours (P < 0.0002). There were no significant differences in IL-2R levels between stage of disease and degree of differentiation within the ovarian tumour group. Nature Publishing Group 1993-08 /pmc/articles/PMC1968563/ /pubmed/8347492 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Owens, O. J.
Taggart, C.
Wilson, R.
Walker, J. J.
McKillop, J. H.
Kennedy, J. H.
Interleukin-2 receptor and ovarian cancer.
title Interleukin-2 receptor and ovarian cancer.
title_full Interleukin-2 receptor and ovarian cancer.
title_fullStr Interleukin-2 receptor and ovarian cancer.
title_full_unstemmed Interleukin-2 receptor and ovarian cancer.
title_short Interleukin-2 receptor and ovarian cancer.
title_sort interleukin-2 receptor and ovarian cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968563/
https://www.ncbi.nlm.nih.gov/pubmed/8347492
work_keys_str_mv AT owensoj interleukin2receptorandovariancancer
AT taggartc interleukin2receptorandovariancancer
AT wilsonr interleukin2receptorandovariancancer
AT walkerjj interleukin2receptorandovariancancer
AT mckillopjh interleukin2receptorandovariancancer
AT kennedyjh interleukin2receptorandovariancancer

Ejemplares similares